Surfactant System in Lung Injury

  • Patricia L. Haslam


The search for therapeutic agents to improve the clinical outcome in adult patients with the acute respiratory distress syndrome (ARDS) has focused on early intervention. A variety of approaches have been attempted using methods that modulate the components of the systemic inflammatory response, but none has led to a major breakthrough. However, early intervention is difficult to achieve for the majority of patients with ARDS who present with the syndrome fully established. Consequently, therapeutic approaches for rescue therapy also need to be developed. This requires a knowledge of events associated with progression and prognosis. The development of ARDS is characterized by damage to the pulmonary vascular endothelium.


Lung Injury Acute Lung Injury Acute Respiratory Distress Syndrome Adult Respiratory Distress Syndrome Surfactant System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Jobe, A. and Ikegami, M. (1987) State of the art: surfactant for the treatment of respiratory distress syndrome. Am. Rev. Respir. Dis., 136, 1256–75.PubMedCrossRefGoogle Scholar
  2. 2.
    Smith, B.T. (1992) Clinical experience with modified natural surfactant, in Pulmonary Surfactant: From Molecular Biology to Clinical Practice (eds B. Robertson, L.M.G. Van Golde and J. J. Batenburg), Elsevier, Amsterdam, pp. 593–604.Google Scholar
  3. 3.
    Morley, C. J. (1992) Clinical experience with artificial surfactants, in Pulmonary Surfactant: From Molecular Biology to Clinical Practice (eds B. Robertson, L.M.G. Van Golde and J. J. Batenburg), Elsevier, Amsterdam, pp. 605–33.Google Scholar
  4. 4.
    Lewis, J.F. and Jobe, A.H. (1993) Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 147, 218–33.PubMedCrossRefGoogle Scholar
  5. 5.
    King, R. J. and Clements, J.A. (1972) Surface active materials from dog lung: composition and physiological correlations. Am. J. Physiol., 223, 715–26.PubMedGoogle Scholar
  6. 6.
    Possmayer, F. (1988) Pulmonary perspective: a proposed nomenclature for pulmonary surfactant associated proteins. Am. Rev. Respir. Dis., 138, 990–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Hills, B.A. (1988) The Biology of Surfactant, Cambridge: Cambridge University Press.Google Scholar
  8. 8.
    Clements, J.A., Hustead, R.I., Johnson, R.P. and Gribetz, I. (1961) Pulmonary surface tension and alveolar stability. J. Appl. Physiol., 16, 444–50.PubMedGoogle Scholar
  9. 9.
    Hills, B.A. (1982) Water repellency induced by pulmonary surfactants. J. Physiol., 325, 175–86.PubMedGoogle Scholar
  10. 10.
    Notter, R.H. and Finkelstein, J.N. (1984) Pulmonary surfactant: an interdisciplinary approach. J. Appl. Physiol., 57, 1613–24.PubMedGoogle Scholar
  11. 11.
    Clements, J.A. (1957) Surface tension of lung extracts. Proc. Soc. Exp. Biol. Med., 95, 170–2.PubMedCrossRefGoogle Scholar
  12. 12.
    Enhorning, G. (1977) Pulsating bubble technique for evaluating pulmonary surfactant. J. Appl. Physiol., 43, 198–203.PubMedGoogle Scholar
  13. 13.
    Klech, H. and Pohl, W. (eds) (1989) Technical recommendations and guidelines for bron-choalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL. Eur. Respir. J., 2, 561–85.Google Scholar
  14. The BAL Co-operative Group Steering Committee (1990) Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am. Rev. Respir. Dis., 141 (suppl.) , S169–202.Google Scholar
  15. 15.
    Hughes, D.A. and Haslam, P.L. (1989) Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis. Chest, 95, 82–9.PubMedCrossRefGoogle Scholar
  16. 16.
    King, R. J. and Clements, J.A. (1972) Surface active materials from dog lung. Method of isolation. Am. J. Physiol., 223, 704–14.Google Scholar
  17. 17.
    Pison, U., Gono, E., Joka, K. and Obladen, M. (1986) High performance liquid chromatography of adult human bronchoalveolar lavage: assay for phospholipid lung profile. J. Chromatogr., 377, 79–89.PubMedGoogle Scholar
  18. 18.
    King, R. J. (1984) Isolation and chemical composition of pulmonary surfactant, in Pulmonary Surfactant (eds B. Robertson, L.M.G. Van Golde and J. J. Batenburg), Elsevier, Amsterdam, pp. 1–15.Google Scholar
  19. 19.
    Hughes, D.A. and Haslam, P.L. (1990) Effect of smoking on the lipid composition of lung lining fluid and relationship between immu-nostimulatory lipids, inflammatory cells and foamy macrophages in extrinsic allergic alveolitis. Eur. Respir. J., 3, 1128–39.PubMedGoogle Scholar
  20. 20.
    Minty, B.D., Jordan, C. and Jones, J.G. (1981) Rapid improvement in abnormal epithelial permeability after stopping cigarettes. BMJ, 282, 1183–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Weaver, T.E. (1988) Pulmonary surfactant-associated proteins. Gen. Pharmacol., 19, 361–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Hawgood, S. (1989) Pulmonary surfactant apoproteins: a review of protein and genomic structure. Am. J. Physiol., 257 L13–22.Google Scholar
  23. 23.
    Whitsett, J.A., Hull, W., Ross, G. and Weaver, T. (1985) Characteristics of human surfactant-associated glycoproteins A. Pediatr. Res., 19, 501–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Hawgood, S., Efrati, H., Schilling, J. and Benson, B. J. (1985) Chemical characterization of lung surfactant apoproteins: amino acid composition, N-terminal sequence and enzymic digestion. Trans. Biochem. Soc., 13, 1092–6.Google Scholar
  25. 25.
    Floros, J., Phelps, D.S., Kourembanas, S. and Taeusch, H.W. (1986) Primary translation products, biosynthesis, and tissue specificity of the major surfactant protein in rat. J. Biol. Chem., 261, 828–31.PubMedGoogle Scholar
  26. 26.
    Persson, A., Chang, D., Rust, K. et al. (1989) Purification and biochemical characterization of CP4 (SP-D): a collagenous surfactant-associated protein. Biochemistry, 27, 6361–7.CrossRefGoogle Scholar
  27. 27.
    Rust, K., Grosso, L., Zhang, V. et al. (1991) Human surfactant protein D: SP-D contains a C-type lectin carbohydrate recognition domain. Arch. Biochem. Biophys., 290, 116–26.PubMedCrossRefGoogle Scholar
  28. 28.
    Curstedt, T., Johansson, J., Persson, P. et al. (1990) Hydrophobic surfactant-associated polypeptides. SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc. Natl. Acad. Sei. USA, 87, 2985–9.CrossRefGoogle Scholar
  29. 29.
    Whitsett, J.A. Ohning, B.L., Ross, G. et al. (1986) Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr. Res., 20, 460–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Takahashi, A. and Fujiwara, T. (1986) Proteo-lipid in bovine lung surfactant: its role in surfactant function. Biochem. Biophys. Res. Commun., 135, 527–32.PubMedCrossRefGoogle Scholar
  31. 31.
    Yu, S.H. and Possmayer, F. (1988) Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant. Biochim. Biophys. Acta, 961, 337–50.PubMedCrossRefGoogle Scholar
  32. 32.
    Yu, S. and Possmayer, F. (1990) Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures. Biochim. Biophys. Acta, 1046, 233–241.PubMedCrossRefGoogle Scholar
  33. 33.
    Takahashi, A., Waring, A. J., Arnirkhaman, J. et al. (1990) Structure function relationships of bovine pulmonary surfactant proteins: SP-B and SP-C. Biochim. Biophys. Acta, 1044, 43–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Williams, M.C. (1977) Conversion of lamellar body membranes into tubular myelin in alveoli of fetal rat lung. J. Cell Biol, 72, 260–77.PubMedCrossRefGoogle Scholar
  35. 35.
    Suzuki, Y. Fujita, Y. and Kogishi, K. (1989) Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am. Rev. Respir. Dis.140, 75–81.PubMedCrossRefGoogle Scholar
  36. 36.
    Williams, M.C., Hawgood, S. and Hamilton, R.I. (1991) Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am. J. Respir. Cell Mol. Biol, 5, 41–50.PubMedCrossRefGoogle Scholar
  37. 37.
    Hallman, M., Katsumi, M. and Wagner, R.M. (1976) Isolated lamellar bodies from rat lung: correlated ultrastructural and biochemical studies. Lab. Invest., 35, 79–86.PubMedGoogle Scholar
  38. 38.
    Sanders, R.I., Hassett, R. J. and Vatter, A.E. (1980) Isolation of lung lamellar bodies and their conversion to tubular myelin figures in vitro. Anat. Rec, 198, 485–501.PubMedCrossRefGoogle Scholar
  39. 39.
    Hawgood, S., Benson, B. J. and Hamilton, R.L. (1985) Effects of a surfactant-associated protein and calcium ions on the structure and surface activity of lung surfactant lipids. Biochemistry, 24, 184–90.PubMedCrossRefGoogle Scholar
  40. 40.
    King, R. J., Carmichael, M.C. and Horowitz, P.M. (1983) Reassembly of lipid-protein complexes of pulmonary surfactant. Proposed mechanism of interaction. J. Biol. Chem., 258, 10672–80.PubMedGoogle Scholar
  41. 41.
    Tanaka, Y., Takei, T., Aiba, T. et al. (1986) Development of synthetic lung surfactants. J. Lipid Res., 27; 475–85.PubMedGoogle Scholar
  42. 42.
    Wright, J.R., Wager, R.E., Hawgood, S. et al. (1987) Surfactant apoprotein Mr = 26 000–36 000 enhances uptake of liposomes by type II cells. J. Biol. Chem.262, 2888–94.PubMedGoogle Scholar
  43. 43.
    Dobbs, L.G., Wright, J.R., Hawgood, S. et al. (1987) Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc. Natl Acad. Sei. USA, 84, 1010–4.CrossRefGoogle Scholar
  44. 44.
    van Iwaarden, F., Weimers, B., Verhoef, J. et al. (1990) Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol Biol, 2, 91–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Kuan, S.-F., Rust, K. and Crouch, E. (1992) Interactions of surfactant protein D with bacterial lipopolysaccharides. J. Clin. Invest., 90, 97–106.PubMedCrossRefGoogle Scholar
  46. 46.
    Hafner, D., Germann, P. and Hauschke, D. (1994) Lung surfactant (LSF) improves gas exchange and histopathology in a model of adult respiratory distress syndrome (ARDS). Am. J. Respir. Crit Care Med., 149, A126.Google Scholar
  47. 47.
    Sweeney, T.D., Reinisch, U.S., Kirk, J.E. et al. (1994) A synthetic phospholipid-KL surfactant improves lung function in a rat model of ARDS. Am. J. Respir. Crit. Care Med., 149, A126.Google Scholar
  48. 48.
    Wright, J.R. and Clements, J.A. (1987) Metabolism and turnover of lung surfactant. Am. Rev. Respir. Dis., 135, 426–44.CrossRefGoogle Scholar
  49. 49.
    Gross, N. J., Barnes, E. and Narine, K.R. (1988) Recycling of surfactant in black and beige mice: pool sizes and kinetics. J. Appl. Physiol., 64, 2017–25.PubMedGoogle Scholar
  50. 50.
    Magoon, M.W., Wright, J.R., Bantussio, A. et al. (1983) Subfractionation of lung surfactant. Implications for metabolism and surface activity. Biochim. Biophys. Acta, 750, 18–31.PubMedCrossRefGoogle Scholar
  51. 51.
    Manabe, T. (1979) Freeze-fracture study of alveolar lining layer in adult rat lungs. J. Ultrastruct. Res., 69, 86–97.PubMedCrossRefGoogle Scholar
  52. 52.
    Baritussio, A., Carraro, R., Bellina, J. et al. (1985) Turnover of phospholipids isolated from fractions of lung lavage fluid. J. Appl. Physiol., 59, 1055–60.PubMedGoogle Scholar
  53. 53.
    Wright, J.R., Wager, R.E., Hamilton, R.L. et al. (1986) Uptake of lung surfactant subfractions into lamellar bodies of adult rabbit lungs. J. Appl. Physiol., 60, 817–25.PubMedGoogle Scholar
  54. 54.
    Kuroki, Y, Mason, R. J. and Voelker, D.R. (1988) Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A. Proc. Natl. Acad. Sei. USA, 85, 5566–70.CrossRefGoogle Scholar
  55. 55.
    Rice, W.R., Ross, G.F., Singleton, FM. et al. (1987) Surfactant-associated protein inhibits phospholipid secretion from type II cells. J. Appl. Physiol., 63, 692–8.PubMedGoogle Scholar
  56. 56.
    Avery, M.E. and Mead, J. (1959) Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Child., 97, 517–23.Google Scholar
  57. 57.
    Verloove-Vanhorick, S.P., Verwey, R.A., Brand, R. et al. (1986) Neonatal mortality risk in relation to gestational age and birth weight. Lancet, i, 55–7.CrossRefGoogle Scholar
  58. 58.
    Kitchen, W.H., Doyle, L.W., Ford, G.W. et al. (1991) Changing two-year outcome of infants weighing 500 to 999 grams at birth: a hospital study. J. Pediatr., 118, 938–43.PubMedCrossRefGoogle Scholar
  59. 59.
    Chida, S., Phelps, D.S., Cordle, C. et al. (1988) Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy. Am. Rev. Respir. Dis., 137, 943–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Seeger, W., Stöhr, G., Wolf, H.R.D. and Neu-hof, H. (1985) Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J. Appl. Physiol., 58, 326–38.PubMedGoogle Scholar
  61. 61.
    Holm, B.A., Notter, R.H. and Finkelstein, JN. (1985) Surface property changes from interactions of albumin with natural lung surfactant extracted lung lipids. Chem. Phys. Lipids, 38, 287–98.PubMedCrossRefGoogle Scholar
  62. 62.
    Holm, B.A. and Notter, R.H. (1987) Effects of hemoglobin and red blood cell membrane lipids on the biophysical and physiological activity of pulmonary surfactant. J. Appl. Physiol., 63, 1434–42.PubMedGoogle Scholar
  63. 63.
    Fuchimukai, T., Fujiwara, T., Takahashi, A. and Enhorning, G. (1987) Artificial pulmonary surfactant inhibited by proteins. J. Appl. Physiol., 57, 1134–42.Google Scholar
  64. 64.
    Holm, B.A., Enhorning, G. and Notter, R.H. (1988) A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem. Phys. Lipids, 49 49–55.PubMedCrossRefGoogle Scholar
  65. 65.
    Seeger, W. Grube, C., Günther, A. and Schmidt, R. (1993) Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur. Respir. J., 6, 971–7.PubMedGoogle Scholar
  66. 66.
    Holm, B.A., Venkitaraman, A.R., Enhorning, G. and Notter, R.H. (1990) Biophysical inhibition of synthetic lung surfactants. Chem. Phys. Lipids, 52, 243–50.PubMedCrossRefGoogle Scholar
  67. 67.
    Seeger, W. Thede, C. Günther, A. and Grube, C. (1991) Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro- comparison to natural surfactant. Biochim. Biophys. Acta, 1081 45–52.PubMedCrossRefGoogle Scholar
  68. 68.
    Ikegami, M., Jobe, A., Jacobs, H. and Jones, S. (1981) Sequential treatments of premature lambs with an artificial surfactant and natural surfactant. J. Clin. Invest., 68, 491–6.PubMedCrossRefGoogle Scholar
  69. 69.
    Ikegami, M., Agata, Y., Elkady, T. et al. (1987) A comparison of four surfactants: in vitro surface properties and responses of preterm lambs to treatment at birth. Pediatrics, 79, 38–46.PubMedGoogle Scholar
  70. 70.
    Venkitaraman, A.R., Hall, S.B., Whitsett, J.A. and Notter, R.H. (1990) Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant proteins. Chem. Phys. Lipids, 56, 1–10.CrossRefGoogle Scholar
  71. 71.
    Venkitaraman, A.R., Baatz, J.E., Whitsett, J.A. et al. (1990) Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins. Chem. Phys. Lipids, 57, 49–57.CrossRefGoogle Scholar
  72. 72.
    Cockshutt, A., Weitz, J. and Possmayer, F. (1990) Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry, 29, 8424–9.CrossRefGoogle Scholar
  73. 73.
    Holm, B.A. (1992) Surfactant inactivation in adult respiratory distress syndrome, in Pulmonary Surfactant: Prom Molecular Biology to Clinical Practice (eds B. Robertson, L.M.G. Van Golde and J. J. Batenburg) Elsevier, Amsterdam, pp. 665–84.Google Scholar
  74. 74.
    Holm, B.A. and Matalon, S. (1989) Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome. Anesth. Analg., 69, 805–18.PubMedCrossRefGoogle Scholar
  75. 75.
    Hallman, M., Spragg, R., Harrell, J.H. et al. (1982) Evidence of lung surfactant abnormality in respiratory failure: study of bronchoal-veolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J. Clin. Invest., 70, 673–83.PubMedCrossRefGoogle Scholar
  76. 76.
    Holm, B.A., Keicher, L., Liu, M. et al. (1991) Inhibition of pulmonary surfactant function by phospholipases. J. Appl. Physiol., 71, 1–5.Google Scholar
  77. 77.
    Passi, R.B. and Possmayer, F. (1981) Surfactant metabolism in acute pancreatitis. Prog. Respir. Res., 15, 136–40.Google Scholar
  78. 78.
    Vadas, P. (1984) Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in Gram negative septic shock. J. Lab. Clin. Med., 104, 873–81.PubMedGoogle Scholar
  79. 79.
    Vadas, P. and Pruzanski, W. (1986) Biology of disease: role of secretory phospholipases A2 in the pathobiology of disease. Lab. Invest., 55, 391–9.PubMedGoogle Scholar
  80. 80.
    Bejar, R., Curbelo, V., Davis, C. and Gluck, L. (1981) Premature labor. II. Bacterial source of phospholipase. Obstet. Gynecol, 57, 479–82.PubMedGoogle Scholar
  81. 81.
    Weiss, S. J. (1989) Tissue destruction by neutrophils. N. Engl. J. Med., 320, 365–76.PubMedCrossRefGoogle Scholar
  82. 82.
    Henson, P.M. and Johnston, R.B. (1987) Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J. Clin. Invest., 79, 669–74.PubMedCrossRefGoogle Scholar
  83. 83.
    Fantone, J.C. and Ward, P.A. (1985) Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relation to human disease. Hum. Pathol, 16, 973–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Esterbauer, H. (1985) Lipid peroxidation products: formation, chemical properties and biological activities, in Free Radicals in Liver Injury (eds G. Poli, K.H. Cheeseman, M.U. Dianzani, et al.), IRL Press, Oxford, pp. 29–47.Google Scholar
  85. 85.
    Ryan, S.F., Ghassibi, Y. and Liau, D.F. (1991) Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am. J. Respir. Cell Mol. Biol, 4, 33–41.CrossRefGoogle Scholar
  86. 86.
    Fowler, A.A., Hamman, R.F., Good, J.T. et al. (1983) Adult respiratory distress syndrome: risks with common predispositions. Ann. Intern. Med., 98, 593–7.PubMedCrossRefGoogle Scholar
  87. 87.
    Montgomery, A.B., Stager, M.A., Carrico, C. J. and Hudson, L.D. (1985) Causes of mortality in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 132, 148.Google Scholar
  88. 88.
    Murray, J.F., Matthay, M.A., Luce, J.M. and Flick, M.R. (1988) An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis., 138, 720–3.PubMedCrossRefGoogle Scholar
  89. 89.
    Bernard, G.R., Artigas, A., Brigham, K.L. et al. (1994) Conference report: The American-European Consenus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med., 149, 818–24.PubMedCrossRefGoogle Scholar
  90. 90.
    Rinaldo, J.E. and Christman, J.W. (1990) Mechanisms and mediators of the adult respiratory distress syndrome. Clin. Chest Med., 11, 621–32.PubMedGoogle Scholar
  91. 91.
    Donnelly, S.C. and Haslett, C. (1992) Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome. Thorax, 47, 260–3.PubMedCrossRefGoogle Scholar
  92. 92.
    Ashbaugh, D.G., Bigelow, D.B., Petty, T.L. and Levine, B.E. (1967) Acute respiratory distress in adults. Lancet, ii, 319–23.CrossRefGoogle Scholar
  93. 93.
    Von Wiehert, P. and Kohl, F.V. (1977) Decreased dipalmitoyllecithin content found in lung specimens from patients with so-called shock-lung. Eur. Intensive Care Med., 3, 27–30.CrossRefGoogle Scholar
  94. 94.
    Petty, T.L., Reiss, O.K., Paul, G.W. et al. (1977) Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock. Am. Rev. Respir. Dis., 115, 531–6.PubMedGoogle Scholar
  95. 95.
    Pison, U., Seeger, W., Buchhorn, R. et al. (1989) Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis., 140, 1033–9.PubMedCrossRefGoogle Scholar
  96. 96.
    Pison, U., Obertacke, U., Brand, M. et al. (1990) Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J. Trauma, 30, 19–26.PubMedCrossRefGoogle Scholar
  97. 97.
    Seeger, W., Pison, U., Buchhorn, T. et al. (1990) Alterations in alveolar surfactant following severe multiple trauma, in Progress in Respiration Research, vol. 25 Basic Research on Lung Surfactant (eds P. von Wiehert and B. Müller), Karger, Basel, pp. 215–23.Google Scholar
  98. 98.
    Seeger, W., Pison, U., Buchhorn, R. et al. (1990) Surfactant abnormalities and adult respiratory failure. Lung, 168(suppl.), 891–902.PubMedCrossRefGoogle Scholar
  99. 99.
    Gregory, T. Longmore, W., Moxley, M. et al. (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest., 88, 1976–81.PubMedCrossRefGoogle Scholar
  100. 100.
    Holter, J.F., Weiland, J.E., Pacht, E.R. et al. (1986) Protein permeability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J. Clin. Invest., 78, 1513–22.PubMedCrossRefGoogle Scholar
  101. 101.
    Fowler, A.A., Walchak, S., Giclas, P.C. et al. (1982) Characterization of antiproteinase activity in the adult respiratory distress syndrome. Chest, 81 (suppl.), 50S-51S.CrossRefGoogle Scholar
  102. 102.
    Lee, C.T. Fein, A.M., Lippman, M. et al. (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N. Engl. J. Med., 304, 192–6.PubMedCrossRefGoogle Scholar
  103. 103.
    Wewers, M.D., Herzyk, D. J. and Gadek J.E. (1988) Alveolar fluid neutrophil elastase activity in the adult respiratory distress syndrome is complexed to alpha-2-macroglobulin. J. Clin. Invest., 82, 1260–7.PubMedCrossRefGoogle Scholar
  104. 104.
    Li, J. J., Sanders, R.L., McAdam, K.P. et al. (1989) Impact of C-reactive protein (CRP) on surfactant function. J. Trauma, 29, 1690–7.PubMedCrossRefGoogle Scholar
  105. 105.
    Berry, D., Ikegami, M. and Jobe, A. (1986) Respiratory distress and surfactant inhibition following vagotomy in rabbits. J. Appl. Physiol., 61, 1741–8.PubMedGoogle Scholar
  106. 106.
    Liau, D.F., Barrett, C.R., Bell, A.L.L. and Ryan, S.F (1985) Normal surface properties of phos-phatidylglycerol-deficient surfactant from dog after acute lung injury. J. Lipid Res., 26, 1338–44.PubMedGoogle Scholar
  107. 107.
    Batenburg, J. J., Klazinga, W. and Van Golde, L.M.G. (1985) Regulation and location of phosphatidylglycerol and phosphatidylinosi-tol synthesis in type II cells isolated from fetal rat lung. Biochim. Biophys. Acta., 833, 17–24.PubMedCrossRefGoogle Scholar
  108. 108.
    Hallman, M., Enhorning, G. and Possmayer, F. (1985) Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant. Pediatr. Res., 19 286–92.PubMedCrossRefGoogle Scholar
  109. 109.
    Beppu, O.S., Clements, J.A. and Goerke, J. (1983) Phosphatidylglycerol-deficient lung surfactant has normal properties. J. Appl. Physiol., 55, 496–502.PubMedGoogle Scholar
  110. 110.
    Gross, N. (1991) Altered surfactant subtypes in an experimental form of ARDS: radiation pneumonitis. Am. J. Physiol., 260, L302–10.Google Scholar
  111. 111.
    Lachmann, B. and van Daal G-J. (1992) Adult respiratory distress syndrome: animal models, in Pulmonary Surfactant: from Molecular Biology to Clinical Practice, (eds B. Robertson, L.M.G. Van Golde and J. J. Batenburg), Elsevier, Amsterdam, pp. 635–63.Google Scholar
  112. 112.
    Klaus, M.H., Clements, J.A. and Havel, H. J. (1961) Composition of surface active material isolated from beef lung. Proc. Natl. Acad. Sei. USA, 47, 1858.CrossRefGoogle Scholar
  113. 113.
    Robillard, E., Alarie, Y., Dagenais-Perusse, P. et al., (1964) Microaerosol administration of synthetic β- γ-dipalmotyl-L-α-lecithin in the respiratory distress syndrome. A preliminary report. Can. Med. Assoc. J., 90, 55–7.PubMedGoogle Scholar
  114. 114.
    Chu, J., Clements, J.A., Cotton, E.K. et al. (1967) Neonatal pulmonary ischaemia: clinical and physiologic studies. Pediatrics, 40, 709–82.PubMedGoogle Scholar
  115. 115.
    Bangham, A.D., Morley, C. J. and Phillips, M.C. (1979) The physical properties of an effective lung surfactant. Biochim. Biophys. Acta, 573, 552–6.PubMedCrossRefGoogle Scholar
  116. 116.
    Enhorning, G. and Robertson, J.B. (1972) Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics, 50, 55–66.Google Scholar
  117. 117.
    Robertson, B. and Enhorning, G. (1974) The alveolar lining of the premature newborn rabbit after pharyngeal deposition of surfactant. Lab. Invest., 31, 54–9.PubMedGoogle Scholar
  118. 118.
    Adams, F.H., Towers, B., Osher, A.B. et al. (1978) Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings. Pediatr. Res., 12, 841–8.PubMedCrossRefGoogle Scholar
  119. 119.
    Fujiwara, T., Chida, S., Watabe, Y. J. et al. (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet, i, 55–9.CrossRefGoogle Scholar
  120. 120.
    Fujiwara, T., Konishi, M., Chida, S. et al. (1990) Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. Pediatrics, 86, 753–64.PubMedGoogle Scholar
  121. 121.
    Soil, R.F., Hoekstra, R.A., Fangmann, J. J. et al. (1990) Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Pediatrics, 85, 1092–102.Google Scholar
  122. 122.
    Hörbar, J.D., Soll, R.F., Schachinger, H. et al. (1990) A European multicenter randomized trial of single dose surfactant therapy for idiopathic respiratory distress syndrome. Eur. J. Pediatr., 149, 416–23.PubMedCrossRefGoogle Scholar
  123. 123.
    Ware, J., Taeusch, H.W., Soll, R.F. and McCor-mick, M.C. (1990) Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. Pediatrics, 85, 1103–7.PubMedGoogle Scholar
  124. 124.
    Hoekstra, R.E., Jackson, J.C., Myers, T.F. et al. (1991) Improved neonatal survival following multiple closes of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics, 88, 10–8.PubMedGoogle Scholar
  125. 125.
    Noack, G., Berggren, P., Curstedt, T., et al. (1987) Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant. Acta Pae-diatr. Scand., 76, 697–705.CrossRefGoogle Scholar
  126. 126.
    Collaborative European Multicenter Study Group (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics, 82, 683–91.Google Scholar
  127. 127.
    Robertson, B. (1990) European multicenter trials of Curosurf for treatment of neonatal respiratory distress syndrome. Lung, 168, 860–3.PubMedCrossRefGoogle Scholar
  128. 128.
    Collaborative European Multicenter Study Group (1991) Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Eur. J. Pediatr., 150, 433–9.CrossRefGoogle Scholar
  129. 129.
    Speer, C.P., Robertson, B., Curstedt, T. et al. (1992) Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics., 89, 13–20.PubMedGoogle Scholar
  130. 130.
    Yu, S., Harding, P.G.R., Smith, N. and Possmayer, F. (1983) Bovine pulmonary surfactant: chemical and physical properties. Lipids, 18, 522–9.PubMedCrossRefGoogle Scholar
  131. 131.
    Enhorning, G., Shennan, A., Possmayer, F. et al. (1985) Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics, 76, 145–53.PubMedGoogle Scholar
  132. 132.
    Dunn, M.S., Shennan, A.T. and Possmayer, F. (1990) Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks’ gestation with respiratory distress syndrome. Pediatrics, 86, 564–71.PubMedGoogle Scholar
  133. 133.
    Dunn, M.S., Shennan, A.T. Zayack, D. and Possmayer, F. (1991) Bovine surfactant replacement therapy in neonates of less than 30 week’s gestation — a randomized controlled trial of prophylaxis versus treatment. Pediatrics, 87, 377–86.PubMedGoogle Scholar
  134. 134.
    Shapiro, D.L., Notter, R.H., Morin, F.C. et al. (1985) Double-blind randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics, 76, 593–9.PubMedGoogle Scholar
  135. 135.
    Kwong, M.S., Egan, E.A., Notter, R.H. and Shapiro, D.L. (1985) Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics, 76, 585–92.PubMedGoogle Scholar
  136. 136.
    Kendig, J.W., Notter, R.H., Cox, C. et al. (1988) Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials. Pediatrics, 82, 756–62.PubMedGoogle Scholar
  137. 137.
    Disse, B., Gortner, L., Weller, E. et al. (1988) Efficacy and standardization of SF-RII: a preparation from bovine lung surfactant, in Surfactant Replacement Therapy in Neonatal and Adult Respiratory Distress Syndrome (ed. B. Lachmann), Springer, Berlin. , pp 37–41.Google Scholar
  138. 138.
    Gortner, L., Bernsau, U., Hellwege, H.H. et al. (1990). A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome. Lung, 168 (suppl.), 864–9.PubMedCrossRefGoogle Scholar
  139. 139.
    Hallman, M., Merritt, T.A., Schneider, H. et al. (1983) Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome. Pediatrics, 71, 473–82.PubMedGoogle Scholar
  140. 140.
    Hallman, M., Merritt, T.A., Jarvenpaa, A.L. et al. (1985) Exogenous human surfactant for treatment of severe respiratory distress syndrome. J. Pediatr., 106, 963–9.PubMedCrossRefGoogle Scholar
  141. 141.
    Merritt, T.A., Hallman, M., Berry, C. et al. (1991) Randomized, placebo-controlled trials of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J. Pediatr., 118, 581–94.PubMedCrossRefGoogle Scholar
  142. 142.
    Durand, D. J., Clyman, R.I., Heymann, M.A. et al. (1985) Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs. J. Pediatr., 109, 775–80.Google Scholar
  143. 143.
    Bose, C., Corbet, A. Bose, G. et al. (1990) Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of synthetic surfactant. J. Pediatr., 117, 947–53.PubMedCrossRefGoogle Scholar
  144. 144.
    Corbet, A., Bucciarelli, R., Goldman, S. et al. (1991) Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. J. Pediatr., 118, 277–84.PubMedCrossRefGoogle Scholar
  145. 145.
    Phibbs, R.H., Ballard, R.A., Clements, J.A. et al. (1991) Initial trials of Exosurf, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics, 88, 1–9.PubMedGoogle Scholar
  146. 146.
    Long, W., Thompson, T., Sundell, H. et al. (1991) Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700 to 1350-gram infants with respiratory distress syndrome. J. Pediatr., 118, 595–605.PubMedCrossRefGoogle Scholar
  147. 147.
    Morley, C. J., Bangham, A.D., Miller, N. and Davis J.A. (1981) Dry artificial surfactant and its effect on very premature babies. Lancet, i, 64–8.CrossRefGoogle Scholar
  148. 148.
    Morley, C. J., Greenough, A., Miller, N.G. et al. (1988) Randomised trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 week’s gestation. Early Hum. Dev., 17, 41–54.PubMedCrossRefGoogle Scholar
  149. 149.
    Ten-Centre Study Group (1987) Ten-centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. BMJ, 294, 991–6.CrossRefGoogle Scholar
  150. 150.
    Morley, C. J. (1989) The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome. Eur. Respir. J., 3 (suppl.), 81s-86s.Google Scholar
  151. 151.
    White, R.T., Damm D., Miller J. et al. (1985) Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature, 317, 361–3.PubMedCrossRefGoogle Scholar
  152. 152.
    Floros, J., Steinbrink, R. Jacobs, K. et al. (1986) Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein. J. Biol. Chem., 261, 9029–33.PubMedGoogle Scholar
  153. 153.
    Pilot-Matias, T. J., Kister, S.E., Fox, J.L. et al. (1989) Structure and organization of the gene encoding human pulmonary surfactant pro-teolipid SP-B. DNA, 8, 75–86.PubMedCrossRefGoogle Scholar
  154. 154.
    Glasser, S.W., Korfhagen, T.R., Weaver, T.E. et al. (1988) cDNA deduced polypeptide structure and chromosomal assignment of human pulmonary surfactant proteolipid SPL(pVal). J. Biol. Chem., 263, 9–12.PubMedGoogle Scholar
  155. 155.
    Glasser, S.W., Korfhagen, T.R., Perme, C.M. et al. (1988) Two SP-C genes encoding human pulmonary surfactant proteolipid. J. Biol. Chem., 263, 10326–31.PubMedGoogle Scholar
  156. 156.
    Voss, T., Melchers, K., Scheirle, G. and Schäfer, K.P. (1991) Structural composition of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A, Am. J. Respir. Cell Mol Biol, 4 88–94.PubMedCrossRefGoogle Scholar
  157. 157.
    Waring, A., Taeusch, W., Bruni, R. et al. (1989). Synthetic amphipathic sequences of surfactant protein-B mimic several physicochemical and in vivo properties of native pulmonary surfactant proteins. Peptide Res; 2 308–13.Google Scholar
  158. 158.
    Rice, W.R, Sarin, V.K, Fox, JL et al. (1989) Surfactant peptides stimulate uptake of phosphatidylcholine by isolated cells. Biochim. Biophys. Acta., 1006, 237–45.PubMedCrossRefGoogle Scholar
  159. 159.
    Baatz, J.E, Sarin, V. Absolom, D.R. et al. (1991) Effects of surfactant-associated protein SP-B synthetic analogs on the structure and surface activity of model membrane bilayers. Chem. Phys. Lipids, 60 163–78.PubMedCrossRefGoogle Scholar
  160. 160.
    Lachmann, B. Robertson, B. and Vogel, J. (1980). In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol. Scand., 24 231–6.PubMedCrossRefGoogle Scholar
  161. 161.
    Lachmann, B., Fujiwara, T., Chida, S., et al. (1983) Surfactant replacement therapy in the experimental adult respiratory distress syndrome (ARDS), in Pulmonary surfactant system (eds E.V. Cosmi and E.M. Scarpelli), Elsevier, Amsterdam, pp. 231–5.Google Scholar
  162. 162.
    Berggren, P., Lachmann, B. Curstedt, T. et al. (1986) Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress induced by repeated lung lavage. Acta Anaesthesiol. Scand., 30 321–8.PubMedCrossRefGoogle Scholar
  163. 163.
    Lachmann, B. (1987) Surfactant replacement in acute respiratory failure: animal studies and first clinical trials, in Surfactant Replacement Therapy in Neonatal and Adult RDS (ed. B. Lachmann), Springer, New York, pp. 207–11.Google Scholar
  164. 164.
    Oetomo Bambang, S., Reijngoud, D-J., Ennema, J. et al. (1988). Surfactant replacement therapy in surfactant-deficient rabbits: early effects on lung function and biochemical aspects. Lung, 166 65–73.CrossRefGoogle Scholar
  165. 165.
    Kobayashi, T., Kataoka, H., Ueda, T. et al. (1984). Effects of surfactant supplement and end-expiratory pressure in lung-lavaged rabbits. J. Appl. Physiol.57 995–1001.PubMedGoogle Scholar
  166. 166.
    Lewis, J.F. Tabor, B., Ikegami, M. et al. (1993) Lung function and surfactant distribution in saline lavaged sheep given instilled versus nebulized surfactant. J. Appl. Physiol.74 1256–64.PubMedCrossRefGoogle Scholar
  167. 167.
    van Daal, G. J. Bos, J.A.H. Eijking, E.P. et al. (1992) Surfactant replacement therapy improves pulmonary mechanics in endstage influenza A in mice. Am. Rev. Respir. Dis., 145, 859–63.PubMedCrossRefGoogle Scholar
  168. 168.
    van Daal, G. J., So, K.L., Gommers, D. et al. (1991) Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth. Analg., 72, 589–95.PubMedCrossRefGoogle Scholar
  169. 169.
    Eijking, E.P., van Daal, G. J., Tenbrinck, R. et al. (1991) Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats. Intensive Care Med., 17, 475–8.PubMedCrossRefGoogle Scholar
  170. 170.
    Lachmann, B., Hallman, M. and Bergmann, K.C. (1987) Respiratory failure following antilung serum: study on mechanisms associated with surfactant system damage. Exp. Lung Res., 12 163–80.PubMedCrossRefGoogle Scholar
  171. 171.
    Harris, J.D., Jackson, F., Moxley, M.A. and Longmore, W. J. (1989) Effect of exogenous surfactant instillation on experimental acute lung injury. J. Appl. Physiol., 66, 1846–51.PubMedGoogle Scholar
  172. 172.
    Lewis, J., Ikegami, M., Higucni, R. et al. (1991) Nebulized vs instilled exogenous surfactant in an adult lung injury model. J. Appl. Physiol., 71, 1270–6.PubMedGoogle Scholar
  173. 173.
    Matalon, S., Holm, B.A. and Notter, R.H. (1987) Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J. Appl. Physiol., 62 756–61.PubMedGoogle Scholar
  174. 174.
    Loewen, G.M., Holm, B.A., Milanowski, I. et al. (1989) Alveolar hyperoxic injury in rabbit receiving exogenous surfactant. J. Appl. Physiol., 66 1087–92.PubMedGoogle Scholar
  175. 175.
    Engstrom, P.C, Holm, B.A. and Matalon, S. (1989) Surfactant replacement attenuates the increase in alveolar permeability in hyperoxia. J. Appl. Physiol., 67, 688–93.PubMedGoogle Scholar
  176. 176.
    Fracica, P. J. Piantadosi, C.A. Young, S.L. and Crapo, J.D. (1992) Artificial surfactant diminishes pathological injury in hyperoxia in primates. Am. Rev. Respir. Dis., 145, A609.Google Scholar
  177. 177.
    Simonson, S.G., Huang, Y.C., Fracica, P. J. et al. (1992) Exogenous surfactant improves oxygenation in hyperoxic lung injury. Am. Rev. Respir. Dis., 145, A610.CrossRefGoogle Scholar
  178. 178.
    Lamm, W. J.E. and Albert, R.K. (1990) Surfactant replacement improves recoil in rabbit lungs after acid aspiration. Am. Rev. Respir. Dis., 142, 1279–83.PubMedCrossRefGoogle Scholar
  179. 179.
    Kobayashi, T., Ganzuka, M., Taniguchi, J. et al. (1990) Lung lavage and surfactant replacement for hydrochloric acid aspiration in rabbits. Acta Anaesthesiol. Scand., 34, 216–21.PubMedCrossRefGoogle Scholar
  180. 180.
    Lachmann, B. and Bergmann, K.C. (1987) Surfactant replacement improves thorax — lung compliance and survival rate in mice with influenza infection. Am. Rev. Respir. Dis., 135, A6.Google Scholar
  181. 181.
    Rinaldo, J.E., Dauber, J.H., Christman, J. and Rogers, R.M. (1984) Neutrophil alveolitis following endotoxemia. Enhancement by previous exposure to hyperoxia. Am. Rev. Respir. Dis., 130, 1065–71.PubMedGoogle Scholar
  182. 182.
    Ishizaka, A., Stephens, K.E., Tazelaar, H.D. et al. (1988) Pulmonary edema after Escherichia coli peritonitis correlates with thiobarbituric-acid-reactive materials in bronchoalveolar lavage fluid. Am. Rev. Respir. Dis., 137, 783–9.PubMedCrossRefGoogle Scholar
  183. 183.
    Oldham, K.T., Guice, K.S., Stetson, P.S. and Wolfe, R.R. (1989) Bacteremia-induced suppression of alveolar surfactant production. J. Surg. Res., 47, 397–402.PubMedCrossRefGoogle Scholar
  184. 184.
    Lewis, J.F., Ikegami, M. and Jobe, A.H. (1990) Altered surfactant function and metabolism in rabbits with acute lung injury. J. Appl. Physiol., 69, 2303–10.PubMedGoogle Scholar
  185. 185.
    Lewis, J.F., Ikegami, M. and Jobe, A.H. (1992) Metabolism of exogenously administered surfactant in the acutely injured lungs of adult rabbits. Am. Rev. Respir. Dis., 145, 19–23.PubMedCrossRefGoogle Scholar
  186. 186.
    Holm, B.A., Notter, R.H., Seigle, J. and Mata-lon S. (1985) Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J. Appl. Physiol., 59, 1402–9.PubMedGoogle Scholar
  187. 187.
    Gross, N. J. and Smith, D.M. (1981) Impaired surfactant phospholipid metabolism in hyperoxic mouse lungs. J. Appl. Physiol., 51, 1198–203.PubMedGoogle Scholar
  188. 188.
    Clark, J.M. and Lambertsen, C. J. (1971) Pulmonary oxygen toxicity: a review. Pharmacol. Rev., 23, 37–133.PubMedGoogle Scholar
  189. 189.
    Matalon, S. and Egan, E.A. (1981) Effects of 100% oxygen breathing on permeability of alveolar epithelium to solute. J. Appl. Physiol., 50, 859–63.PubMedGoogle Scholar
  190. 190.
    Matalon, S. and Egan, E.A. (1984) Interstitial fluid volumes and albumin spaces in pulmonary oxygen toxicity. J. Appl. Physiol., 57, 1767–72.PubMedGoogle Scholar
  191. 191.
    Matalon, S. and Cesar, M.C. (1985) Effects of 100% oxygen breathing on the capillary filtration coefficient in rabbit lungs. Microvasc. Res., 29, 70–80.PubMedCrossRefGoogle Scholar
  192. 192.
    Ennema, J. J., Kobayashi, T., Robertson, B. and Curstedt, T. (1988) Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia. Acta Anaesthesiol. Scand., 32, 665–71.PubMedCrossRefGoogle Scholar
  193. 193.
    Ashbaugh, D.G. and Uzawa, T. (1968) Respiratory and hemodynamic changes after injection of free fatty acids. J. Surg. Res., 8, 417–23.PubMedCrossRefGoogle Scholar
  194. 194.
    Greenfield, L. J., Barkett, V.M. and Coalson, J. J. (1968) The role of surfactant in the pulmonary response to trauma. J. Trauma, 8, 735–41.PubMedCrossRefGoogle Scholar
  195. 195.
    Grossman, R.F., Jones, J.G. and Murray, J.F. (1980) Effects of oleic acid-induced pulmonary edema on lung mechanics. J. Appl. Physiol., 48, 1045–51.PubMedGoogle Scholar
  196. 196.
    Guerrero, M., Donoso, P., Puig, F. and Oyar-zun, M. J. (1982) Interference of free fatty acids on pulmonary surfactant in rabbits. Arch. Biol Med. Exp., 15, 43–8.Google Scholar
  197. 197.
    Hall, S.B., Notter, R.H., Smith, R. J. and Hyde, R.W. (1990) Altered function of pulmonary surfactant in fatty acid lung injury. J. Appl. Physiol., 69, 1143–9.PubMedGoogle Scholar
  198. 198.
    Zelter, M., Escudier, J., Hoeffel, J.M. and Murray, J.F. (1991) Effects of aerolized artificial surfactant on repeated oleic acid injury in sheep. Am. Rev. Respir. Dis., 141, 1014–9.CrossRefGoogle Scholar
  199. 199.
    Lachmann, B. (1987) The role of pulmonary surfactant in the pathogenesis and therapy of ARDS, in Update in intensive care and emergency medicine (ed. J.L. Vincent), Springer, Berlin, pp. 123–4.Google Scholar
  200. 200.
    Richman, P.S., Spragg, R.G., Robertson, B. et al. (1989) The adult respiratory distress syndrome: first trials with surfactant replacement. Eur. Respir. J. , 2 (suppl. 3), 109s-111s.Google Scholar
  201. 201.
    Nosaka, S., Sakai, T, Yonekura, M. and Yoshi-kawa, K. (1990) Surfactant for adults with respiratory failure. Lancet, 336, 947–8, (letter).PubMedCrossRefGoogle Scholar
  202. 202.
    Lewis, J., Dhillon, J. and Frewen, T. (1994) Exogenous surfactant therapy in pediatric patients with ARDS. Am. J. Respir. Crit. Care Med., 149, A125.Google Scholar
  203. 203.
    Wiedemann, H., Baughman, R., de Boisblanc, B. et al. (1992) A multi centred trial in human sepsis-induced ARDS of an aerosolized synthetic surfactant (Exosurf). Am. Rev. Respir. Dis., 145 (suppl.) , A184.Google Scholar
  204. 204.
    Anzueto, A., Baughman, R., Guntupaill, K. et al. (1994) An international randomized, placebo-controlled trial evaluating the safety and efficacy of aerosolized surfactant in patients with sepsis-induced ARDS. Am. J. Respir. Crit. Care Med., 149, A567.CrossRefGoogle Scholar
  205. 205.
    Gregory, T. J., Gadek, J.E., Weiland, J.E. et al. (1994) Survanta supplementation in patients with acute respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care Med., 149, A567.Google Scholar
  206. 206.
    Gregory, T. J., Longmore, W. J., Moxley, M.A. et al. (1994) Surfactant repletion following Sur-vanta supplementation in patients with acute respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care Med., 149, A124.Google Scholar
  207. 207.
    Clarke, S. (1990) Principles of inhaled therapy, In Respiratory Medicine (eds G. J. Gibson, D.M. Geddes and B.A.L. Bretius), Baillière Tindall, London, pp. 386–406.Google Scholar
  208. 208.
    Marks, L.B., Notter, R.H., Oberdorster, G. and McBride, J.T. (1983) Ultrasonic and jet aeroso-lisation of phospholipids and the effects on surface activity. Pediatr. Res., 17, 742–7.PubMedCrossRefGoogle Scholar
  209. 209.
    Lewis, J.F., Ikegami, M., Jobe, A. and Absolom D. (1993) Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. Am. Rev. Respir. Dis., 147, 1364–70.PubMedCrossRefGoogle Scholar
  210. 210.
    Macnaughton, P.D. and Evans, T.W. (1994) The effect of exogenous surfactant therapy on lung function following cardiopulmonary bypass. Chest, 105, 421–5.PubMedCrossRefGoogle Scholar
  211. 211.
    Haslam, P.L., Hughes, D.A., Macnaughton, P.D. et al. (1994) Surfactant replacement therapy in late-stage adult respiratory distress syndrome. Lancet, 343, 1009–11.PubMedCrossRefGoogle Scholar
  212. 212.
    Oguchi, K., Ikegami, M., Jacobs, H. and Jobe, A. (1985) Clearance of large amounts of natural surfactant and DPPC from lungs of 3-day old rabbits following tracheal injection. Exp. Lung Res. , 9, 221–35.PubMedCrossRefGoogle Scholar
  213. 213.
    Hallman, M., Merritt, T.A., Pohjavuori, M. and Gluck, L. (1986) Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr. Res., 20, 1228–35.PubMedCrossRefGoogle Scholar
  214. 214.
    Geiger, K., Gallagher, M.L. and Hedley-Whyte, J. (1975) Cellular distribution and clearance of aerosolized dipalmitoyl lecithin. J. Appl. Physiol., 39, 759–66.PubMedGoogle Scholar
  215. 215.
    Metz, C. and Sibbald, J. (1991) Anti-inflammatory therapy for acute lung injury. A review of animal and clinical studies. Chest, 100, 1110–19.PubMedCrossRefGoogle Scholar
  216. 216.
    Schonfeld, S.A., Ploysongsang, Y. DiLisior, D. et al. (1983) Fat embolism prophylaxis with corticosteroids. A prospective study in high risk patients. Ann. Intern. Med., 99, 438–43.PubMedCrossRefGoogle Scholar
  217. 217.
    Meduri, G.U., Belenchia, J.M., Estes, R. J. et al. (1991) Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest, 100, 943–52.PubMedCrossRefGoogle Scholar
  218. 218.
    Braude, S., Haslam, P. L. Hughes, D. A. et al. (1992) ‘Chronic’ adult respiratory distress syndrome. A role for corticosteroids? Crit. Care Med., 20, 1187–9.PubMedCrossRefGoogle Scholar
  219. 219.
    Smith, B.T. and Sabry, K. (1983) Glucocor-ticoid-thyroid synergism in lung maturation: a mechanism involving epithelial-mesenchymal interaction. Proc. Natl. Acad. Sei. USA, 80, 1951–4.CrossRefGoogle Scholar
  220. 220.
    Kaltreider, H.B. and Salmon, S.E. (1973) Immunology of the lower respiratory tract: functional properties of bronchoalveolar lymphocytes obtained from the normal canine lung. J. Clin. Invest., 52, 2211–7.PubMedCrossRefGoogle Scholar
  221. 221.
    Ansfield, M. J., Kaltreider, H.B., Benson, B. J. and Caldwell, J.L. (1979) Immunosuppressive activity of canine pulmonary surface active material. J. Immunol., 122, 1062–6.PubMedGoogle Scholar
  222. 222.
    Wilsher, M.L., Hughes, D.A. and Haslam, P.L. (1988) Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes. Thorax, 43, 354–9.PubMedCrossRefGoogle Scholar
  223. 223.
    Wilsher, M.L., Hughes, D.A. and Haslam, P.L. (1988) Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile. Clin. Exp. Immunol., 73, 117–22.PubMedGoogle Scholar
  224. 224.
    Schwartz, L.W. and Christman, C.A. (1979) Alveolar macrophage migration: influence of lung lining material and acute lung insult. Am. Rev. Respir. Dis., 120, 429–39.PubMedGoogle Scholar
  225. 225.
    Hoffman, R.M., Claypool, W.D., Katyal, S.L., et al. (1987) Augmentation of rat alveolar macrophage migration by surfactant protein. Am. J. Respir. Dis., 135, 1358–62.Google Scholar
  226. 226.
    Wright, J.R. and Youmans, D.C. (1991) Surfactant protein SP-A stimulates migration of alveolar macrophages. Am. Rev. Respir. Dis., 143, A314.Google Scholar
  227. 227.
    Tenner, A. J., Robinson, S.L., Borchelt, J. and Wright, J.R. (1989) Human pulmonary surfactant protein (SP-A), a protein structurally homologous to Clq, can enhance FcR- and CR1-mediated phagocytosis. J. Biol. Chem., 264, 13923–8.PubMedGoogle Scholar
  228. 228.
    van Iwaarden, J.F., van Strijp, J.A., Ebskamp, M. J. et al. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am. J. Physiol., 261, L204–9.Google Scholar
  229. 229.
    LaForce, F.M., Kelly, W. J. and Huber G.L. (1973) Inactivation of Staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material. Am. Rev. Respir. Dis., 108, 784–90.PubMedGoogle Scholar
  230. 230.
    Juers, J.A., Rogers, R.M., McCurdy, T.B. and Cook, W.W. (1976) Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material. J. Clin. Invest., 58, 271–5.PubMedCrossRefGoogle Scholar
  231. 231.
    Weiland, J.E., Davis, W.B. and Holter, J.F. (1986) Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathological significance. Am. Rev. Respir. Dis., 133, 218–25.PubMedGoogle Scholar
  232. 232.
    Speer, C.P., Götze, B., Robertson, B. and Cur-stedt, T. (1991) The effect of natural porcine surfactant (Curosurf) on the phagocytosis-associated functions of human neutrophils, in The Surfactant System of the Lung. Prevention and Treatment of Neonatal and Adult Respiratory Distress Syndrome (eds E.V. Cosmi, G.C.Di Renzo and M.M. Anceschi), Macmillan, London, pp. 142–50.Google Scholar
  233. 233.
    Zetterberg, G., Curstedt, T., Eklund, A. et al. (1992) Increased expression of adhesion proteins (MAC-1) and altered metabolic response in human leukocytes exposed to surfactant in vitro. APMIS, 100, 695–700.PubMedCrossRefGoogle Scholar
  234. 234.
    Thomassen, M. J., Meeker, D.P., Antal, J.M. et al. (1992) Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am. J. Respir. Cell. Mol. Biol., 7, 257–60.PubMedCrossRefGoogle Scholar
  235. 235.
    Speer, C.P., Götze, B., Curstedt, T. and Robertson, B. (1991) Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr. Res., 30, 69–74.PubMedCrossRefGoogle Scholar
  236. 236.
    Tracey, K. J., Beutler, B., Lowry S.F. et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science, 234, 470–4.PubMedCrossRefGoogle Scholar
  237. 237.
    Beutler, B. and Cerami, A. (1987) Cachectin: more than a tumor necrosis factor. N. Engl. Med., 316, 379–80.CrossRefGoogle Scholar
  238. 238.
    Strieter, R.M., Chensue, S.W., Basha, M.A. et al. (1990) Human alveolar macrophage gene expression of interleukin-8 by tumour necrosis factor-α, lipopolysaccharide, and interleu-kin-1β. Am. J. Respir. Cell. Mol. Biol., 2, 321–6.PubMedCrossRefGoogle Scholar
  239. 239.
    Ziegler, E. J., Fisher, C. J., Sprung, C.J. et al. (1991) Treatment of Gram-negative bacteria and septic shock with HA1A human monoclonal antibody against endotoxin. A randomised double blind, placebo controlled trial. N Engl. J. Med., 324, 429–36.PubMedCrossRefGoogle Scholar
  240. 240.
    Beutler, B., Milsark, I.W. and Cerami, A.C. (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science, 229, 869–71.PubMedCrossRefGoogle Scholar
  241. 241.
    Tracey, K. J., Fong, Y., Hesse, D.G. et al. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacterae-mia. Nature, 330, 662–4.PubMedCrossRefGoogle Scholar
  242. 242.
    Suffredini, A.F., Reda, D., Agosti, J. and Banks, S. (1994) Antiinflammatory effects of recombinant tumor necrosis factor receptor (TNFR:Fc) in normal humans following intravenous endotoxin. Am. J. Respir. Crit. Care Med., 149, A240.Google Scholar
  243. 243.
    Wollner, A., Wollner, S. and Raffin, T.A. (1994) Acting via A2 receptors, adenosine inhibits the adhesive capacity of CD11b/CD18 on endotoxin-stimulated neutrophils. Am. J. Respir. Crit. Care Med., 149, A231.Google Scholar
  244. 244.
    Ridings, P.C., Windsor, A.C. J., Jutila, M.A. et al. (1994) A dual binding monoclonal antibody to E-selectin and L-selectin receptors prevents sepsis induced lung injury without reducing neutrophil integrin expression. Am. J. Respir. Crit. Care Med., 149, A429.Google Scholar
  245. 245.
    Karzai, W., Natanson, C., Patterson, M. et al. (1994) Effects of a murine monoclonal antibody (MAb) against leukocyte CD11b adhesion protein during toxic oxygen exposure in rats. Am. J. Respir. Crit. Care Med., 149, A430.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1996

Authors and Affiliations

  • Patricia L. Haslam

There are no affiliations available

Personalised recommendations